These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
52 related articles for article (PubMed ID: 1436238)
1. Glutathione S-transferase activity in human breast tumors. Colovai AI; Stoica A; Cinca SA; Marin M; Gruia M; Condrea I; Petrescu D; Dutu R Neoplasma; 1992; 39(4):249-54. PubMed ID: 1436238 [TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of glutathione S-transferase-pi in invasive breast cancer. Huang J; Tan PH; Thiyagarajan J; Bay BH Mod Pathol; 2003 Jun; 16(6):558-65. PubMed ID: 12808061 [TBL] [Abstract][Full Text] [Related]
3. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization. Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228 [TBL] [Abstract][Full Text] [Related]
4. Nuclear morphometry and glutathione S-transferase pi expression in breast cancer. Huang J; Bay BH; Tan PH Oncol Rep; 2000; 7(3):609-13. PubMed ID: 10767377 [TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance. Arpino G; Weiss H; Lee AV; Schiff R; De Placido S; Osborne CK; Elledge RM J Natl Cancer Inst; 2005 Sep; 97(17):1254-61. PubMed ID: 16145046 [TBL] [Abstract][Full Text] [Related]
6. Biochemically estrogen receptor-negative, progesterone receptor-positive breast carcinoma. Immunocytochemical hormone receptors and prognostic factors. Keshgegian AA Arch Pathol Lab Med; 1994 Mar; 118(3):240-4. PubMed ID: 8135626 [TBL] [Abstract][Full Text] [Related]
7. Glutathione transferase activity and isoenzyme composition in primary human breast cancers. Shea TC; Claflin G; Comstock KE; Sanderson BJ; Burstein NA; Keenan EJ; Mannervik B; Henner WD Cancer Res; 1990 Nov; 50(21):6848-53. PubMed ID: 2208151 [TBL] [Abstract][Full Text] [Related]
8. Lactate dehydrogenase in breast carcinoma: correlation with estrogen and progesterone receptors. Brentani MM; Nagai MA Cancer Detect Prev; 1983; 6(1-2):241-7. PubMed ID: 6883383 [TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of estrogen receptor-alpha and -beta messenger RNA expression in breast carcinoma by real-time polymerase chain reaction. Iwao K; Miyoshi Y; Egawa C; Ikeda N; Tsukamoto F; Noguchi S Cancer; 2000 Oct; 89(8):1732-8. PubMed ID: 11042568 [TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of intra-tumoral estradiol level in breast cancer patients. Miyoshi Y; Akazawa K; Kamigaki S; Ueda S; Yanagisawa T; Inoue T; Yamamura J; Taguchi T; Tamaki Y; Noguchi S Cancer Lett; 2004 Dec; 216(1):115-21. PubMed ID: 15500955 [TBL] [Abstract][Full Text] [Related]
11. Relation of glutathione S-transferase alpha and mu isoforms to response to therapy in human breast cancer. Alpert LC; Schecter RL; Berry DA; Melnychuk D; Peters WP; Caruso JA; Townsend AJ; Batist G Clin Cancer Res; 1997 May; 3(5):661-7. PubMed ID: 9815734 [TBL] [Abstract][Full Text] [Related]
12. Correlation of clinical, pathological status, hormone receptor and C-erbB-2 oncoprotein in breast cancer patients. Aryandono T; Harijadi ; Ghozali A Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():600-6. PubMed ID: 10895217 [TBL] [Abstract][Full Text] [Related]
13. A pilot study of pi-class glutathione S-transferase expression in breast cancer: correlation with estrogen receptor expression and prognosis in node-negative breast cancer. Gilbert L; Elwood LJ; Merino M; Masood S; Barnes R; Steinberg SM; Lazarous DF; Pierce L; d'Angelo T; Moscow JA J Clin Oncol; 1993 Jan; 11(1):49-58. PubMed ID: 8418241 [TBL] [Abstract][Full Text] [Related]
14. Determination of threshold values for determining the size of the fraction of steroid hormone receptor-positive tumor cells in paraffin-embedded breast carcinomas. Leers MP; Hoop JG; van Beers M; van Rodijnen N; Pannebakker M; Nap M Cytometry B Clin Cytom; 2005 Mar; 64(1):43-52. PubMed ID: 15668953 [TBL] [Abstract][Full Text] [Related]
15. Main drug-metabolizing enzyme systems in human breast tumors and peritumoral tissues. Albin N; Massaad L; Toussaint C; Mathieu MC; Morizet J; Parise O; Gouyette A; Chabot GG Cancer Res; 1993 Aug; 53(15):3541-6. PubMed ID: 8339260 [TBL] [Abstract][Full Text] [Related]
16. GST-pi expression correlates with oxidative stress and apoptosis in breast cancer. Huang J; Tan PH; Tan BK; Bay BH Oncol Rep; 2004 Oct; 12(4):921-5. PubMed ID: 15375523 [TBL] [Abstract][Full Text] [Related]
17. Significance of the O6-methylguanine-DNA methyltransferase and glutathione S-transferase activity in the sera of patients with malignant and benign ovarian tumors. Akçay T; Dinçer Y; Alademir Z; Aydinli K; Arvas M; Demirkiran F; Kösebay D Eur J Obstet Gynecol Reprod Biol; 2005 Mar; 119(1):108-13. PubMed ID: 15734094 [TBL] [Abstract][Full Text] [Related]
18. [Immunohistochemical investigation of estrogen and progesterone receptors in breast tumors]. Ellinidi VN; Anikseeva NV; Goncharova OA; Krasnozhon DA; Fedorov KA Vopr Onkol; 2004; 50(2):234-6. PubMed ID: 15176229 [TBL] [Abstract][Full Text] [Related]
19. [Cancer of the breast and the receptor status]. Buonomo O; Serao A; Muggianu A; Guglielmelli E; Davoli E; Amori A G Chir; 1991 Apr; 12(4):274-7. PubMed ID: 1911078 [TBL] [Abstract][Full Text] [Related]
20. Relationships of steroid hormone receptors, age and histological characteristics in human breast cancer. Mureşan Z; Duţu R; Voiculetz N Neoplasma; 1986; 33(3):371-7. PubMed ID: 3016577 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]